Bank of America is next year going to start charging most holders of its debit cards $5 a month if they use them to make purchases. It's the biggest sign so far of how new bank regulations are going to mean big changes for the millions of customers who have come to rely on cards that are tied to their checking accounts — and don't rack up potentially huge interest bills.
Mitt Romney may be back on track to the Republican presidential nomination.
It's still early and nothing is certain, of course. But the signs are that Romney has resumed what seemed, until a few weeks ago, his steady march towards becoming his party's standard bearer against President Obama in the 2012 presidential race.
If that Obama-Romney race should happen, by the way, Harvard Law School couldn't lose since it would be the first time two of its graduates faced each other as major-party nominees for the White House.
Last week, Adm. Mike Mullen, the departing head of the Joint Chiefs of Staff, sat in front of Congress, where he described the Haqqani Network as a "veritable arm of Pakistan's Inter-Services Intelligence agency."
The militant group has long been considered one of the most dangerous insurgent forces in the decade-long war in Afghanistan. Their estimated 5,000 to 15,000 fighters, led by militant Jalaluddin Haqqani, roam the mountainous region between Pakistan and Afghanistan, where they carry out deadly roadside bomb attacks, kidnappings and extortion plots.
For decades, smokers behind the iron curtain had special help when it came to quitting smoking. A pill derived from the seeds of the Golden Rain acacia tree helped lessen cravings for nicotine.
A Bulgarian pharmaceutical company has sold the drug in Eastern Europe as under the brand name Tabex since the 1960s. In Poland, where it remains popular, a course of treatment costs about $15. It's not approved for use in the U.S.